2-61478844-C-A not specified Uncertain significance (Mar 28, 2025) 3982862 2-61478848-T-C not specified Uncertain significance (Apr 15, 2025) 3982864 2-61478944-G-A not specified Uncertain significance (Oct 26, 2021) 2257298 2-61481235-CTTGAT-C XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073395 2-61481268-G-C not specified Uncertain significance (Dec 02, 2021) 2263176 2-61482950-T-A Likely benign (Jul 31, 2018) 748180 2-61483031-C-A XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073407 2-61484076-C-T Benign (Dec 31, 2019) 775172 2-61484077-G-A not specified Uncertain significance (Mar 01, 2025) 3817786 2-61484089-G-C XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073406 2-61485919-A-T not specified Uncertain significance (Sep 27, 2024) 3471370 2-61486689-CCTCGTGATCCACCCAACTCAGACTAATGTTTTAATCTAATGAATGCTAACTGGTGAGTATTTTCACAAGCAGAAATAACATCAATCAATTACTCTCAGAAAATAAGAAAGACTATGGATTTCTATTATTTTTTTGAAACTGAATCTTGCCATGTTGCCTAAACTGGACTTGAGCTGGGGTGATTCGCCTGCCTTACCCTCCCTGGTGGTTGGGATTACAGGTGCATGCTACAATGCCCAGTAAGATTTTCATGATTCTAAGTAAACTGAGTTATACTTAAAGAGTAACTTCTTGTTCTTTTTTTTTTTTTGAGACGAAGTTTCCCACTTGTGGCCCAGACTGGGGTGCAATGGCGCAATCTTGGCTCACTGTCACCTCCACCTCTGGGGTTCAAGTGATTCTCCTGCCTCAGCCTCCTGACTTCAAGTGATCCACCCGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCGTGAAAAGCCAAGACAAGGAAAATAAACACAATGTTTCATGTGAACAAATATCCCAAACTTTAACATTAATGTTACAAAAGATGATACCCTTTGTATTATTCCCACTGTGCTCCCGACACGTGCTCAAGCTTCTTGTAAATTACAAACATCACAATTCCTTCAATACATCTTACTTTCTGCTTTCAAATTTTAAATACAGTTCTGTTCACATAATACGCATGTTCAGAACCTTTCGATATTTAGGTTAGCCAACTTAAGTATTCCACAAGAATTATATTCAGAACAAGTTTACTGAAAAGTATTTCCTTAACAAGAAACAATACTGAAATTTCAAAACTATGAAAATAACTAGCACACTTGTAAAAAAAAAAACCAAAAAACAAAAAACCAACACTATTCCAAGTAATAGTAGTATTAGAATTTTTTGGACTCTCCCAAGGCTCAATTGAATAACAAGAATGAAACGATACAGTTAAAACCTAAAACTAATTCACAATTTTACAAGTTGAGGCATACGCAGCTGGTTTTTATTACTGAAAATGATTTCCTTTTCTGCAAATCATTTAGGAAAAAGGGTGTAAAAAAGACTTTCAGGCCTTTAATCTGGGAAGCAATCACTTTGCTAAAGAGGTAAAGTAATGACAACTTTGTAGCTCTAGCAATTGTTCTAAAAATCAAGAGGAATGCAAAAACTGCACCGGTACTCCATTAATTAAATCCTCCTAACCTATCTATGGAAACATAAAATGACCCAATTTTCTTAGCTATCTTGTTACATATCACCACCCTTCGCTACTGATTAACAGCAGTTTCTTTTGAAGATGGAATACAGCTATTAGTATATTAACGTAAGGACTACAATAAATAAAATGCCATAAAATAACCACAAAGTTGATATGCTTTAAATTAGCAAAATGCACATAATAGAGTATAGCATATTCCATAAAACACAGCATCAACACTAGAAATCAAAAGCAAAGCATCTCTCACTTACCATCTGTGGATCATTGGATCGGCTCACCCAACCAGATATTAACTTTAAAGTTTCCCTTTTTACAGTTCGCATACTTCTAATCAATGGTTGCTTTGTAACCATTTCACCTACAAAACAGAATCAAATGGAATCTAATTTTACCACTAAACTTATACAGTGGTACTCAGGTGTACATTAGATGCAATTCCATTTTACCATTAAAAAGTTTAAAGCCAAAAGTTCACAAAATTTATTGGGAAAATAAGCTTTAAGACTAATTTTAAAAGGGAAAGGTACACTTAACTGTTTTAAATATGTCTAGGGTCATTTGGGAAATGGGAGGTCTGATTTAAATCTGTAAAAAACATCAAATGTTTGACTTAAGGCAGTAGAAGAGAAGTGGTTTGTTTATACTGCATTGTGTAAGAAATCAGAATCACCTACCATTAGCTTGGATAGCTGCAGAAATATTTTCACTGAGGCACTTGTATACATTAAGCATATCTAAATAAATTCTTCCAAGCTGAATTACAAAGGGGTGTCCAACAGCTTTGCAGGCTCTCACATTTGTTTTCAAAATGCTACCAAGCTGCTTGACTGTTTCAGGATCTTTCAGTATATCCACATTCTTGGAGGAAAAAAAGCAAATTCCATTTATCATATAAGAATTATCCACGGCTGGGAACAGTGGCTCACGCCTGTAATCCCAGCACTCTGAGAGGCCGAGGCGGGCGGATGATGAGTTCAGGAGATCGGGACCATCCTGGATAACACGGTGAAACCCCGTCTCTACTAAAAATACAAAAAAAATAGCCAGGCGTGGTGGCAGCCGCCTGTAGTCCCACCTACTCGGGAGGTTGAGGCAGGAGAACGGCGTGAACGCTAGAGATGGAGTTTGCAGTGAGCCGAGATCGCACCACTGCACTCCAGCCTGGGCGAAAGAGCAAGACTCCGTCTCAAAAAAAAAAAAAGAATTATCCATCATAATGGCCAGGCGAGGTGGCTCACACCTATAATCCCAGCACTTTGGGAGGCTGAGTCGGGTGCATCACCTGAGGTCGGGAGTTCAAGACCAGCCTGACCAACATGGAGAAACCCTGTCTCTACTAAAAATACAAAATTAGCCAGGCACAATGGTGCTTGCTTGTAATCCCAGCCACTTGGGAGGCTGAGGCAGGAGAACTGCTTGAGCTCGGGAGGCAGAGGTTGCAGTGAGCCGAGATCACGCCATTGCACTCCAGCCCGGGCACCAAGAGTGAAACTCCATCTCAAAAAAAAAAAAAATCCACATAATTACCAAAGCAAAAGCCATTACGCTTCCCTTACCCTAAACCATATTTATAATCCCAAATGGTAAAAACGAACACAAACGCCTTTTTGTCTACATCTACTTAAGAATGAAGTAATATAGTTCTATTTTTTTTTTTTTGGGACGGAGTCTCGTTCTGTTGCCCAGGCTAGAGTGCAGCGGCGTGATCTCGGCTCACTGCAAGCTCTGCCTCCCAGGTTCACGCCATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGACTTACAGGCGCCCGCCGCCACACTCAGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACTG-C XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073412 2-61488185-G-A XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073413 2-61488207-C-T Likely benign (Apr 01, 2022) 737667 2-61488243-A-C not specified Uncertain significance (Jan 23, 2024) 3191228 2-61488631-G-A Benign (Jun 13, 2018) 734585 2-61488644-A-C XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073404 2-61488648-C-A XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073403 2-61490643-T-G not specified Uncertain significance (May 19, 2025) 3982865 2-61490664-C-T not specified Uncertain significance (Apr 05, 2025) 3982863 2-61490712-T-A Seizure Uncertain significance (Apr 20, 2023) 2499559 2-61490715-T-G XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073402 2-61492034-C-A XPO1-associated Neurodevelopmental Disorder Pathogenic (Jul 21, 2025) 4073411 2-61492047-A-C Likely benign (Dec 31, 2019) 720238 2-61492336-T-A Prostate adenocarcinoma • Breast neoplasm • B-cell chronic lymphocytic leukemia • Malignant neoplasm of body of uterus • Neoplasm of the large intestine Likely pathogenic (May 31, 2016) 376696